Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

University Of Birmingham

🇸🇪Sweden

Country: 🇸🇪Sweden

Ownership: Private

Established: 1900-05-01

Employees: 5K

Market Cap: -

Website: http://www.general.bham.ac.uk

Clinical Trials

Methods of T Cell Depletion Trial (MoTD)

Phase 2

Recruiting

Conditions: Acute Myeloid Leukemia
Myelodysplastic Syndromes
Non Hodgkin Lymphoma
Hodgkin Lymphoma
Chronic Myelogenous Leukemia
Myelofibrosis
Acute Lymphoblastic Leukemia
Chronic Myelomonocytic Leukemia
Multiple Myeloma

Interventions: Drug: Thymoglobulin
Drug: Cyclophosphamide
Drug: Cyclosporine
Drug: Sirolimus
Drug: Mycophenolate Mofetil

First Posted Date: 2021-05-17

Last Posted Date: 2023-09-28

Lead Sponsor: University of Birmingham

Target Recruit Count: 400

Registration Number: NCT04888741

Locations: 🇬🇧
University Hospital of Wales, Cardiff, Wales, United Kingdom
🇬🇧
Queen Elizabeth Hospital, Birmingham, United Kingdom
🇬🇧
Bristol Haematology and Oncology Centre, Bristol, United Kingdom

and more 12 locations

Evaluation of the Mechanisms of Sarcopenia in Chronic Inflammatory Disease: Protocol for a Prospective Cohort Study

Conditions: Chronic Liver Disease
Inflammatory Bowel Diseases
Rheumatoid Arthritis

First Posted Date: 2021-02-02

Last Posted Date: 2021-02-02

Lead Sponsor: University of Birmingham

Target Recruit Count: 170

Registration Number: NCT04734496

Locations: 🇬🇧
Institute of Inflammation and Ageing (IIA) University of Birmingham Research Laboratories, Birmingham, West Midlands, United Kingdom

STOPping Anticoagulation for Isolated or Incidental Subsegmental Pulmonary Embolism

Phase 3

Conditions: Subsegmental Pulmonary Embolism Nos

Interventions: Drug: Warfarin
Other: No treatment
Drug: direct oral anticoagulants
Drug: Low molecular weight heparin

First Posted Date: 2021-01-27

Last Posted Date: 2021-09-29

Lead Sponsor: University of Birmingham

Target Recruit Count: 1466

Registration Number: NCT04727437

Locations: 🇬🇧
Surrey & Sussex Healthcare NHS Trust, Redhill, United Kingdom

Sputum Colour Charts to Guide Antibiotic Self-treatment of Acute Exacerbation of COPD (Colour COPD)

Not Applicable

Conditions: Pulmonary Disease, Chronic Obstructive

First Posted Date: 2021-01-12

Last Posted Date: 2022-11-10

Lead Sponsor: University of Birmingham

Target Recruit Count: 2954

Registration Number: NCT04705233

Locations: 🇬🇧
West Midlands Clinical Research Network, Birmingham, United Kingdom

Preventing Stroke, Premature Death and Cognitive Decline in a Broader Community of Patients With Atrial Fibrillation

Phase 4

Recruiting

Conditions: Atrial Fibrillation

Interventions: Drug: Direct Oral Anticoagulants

First Posted Date: 2021-01-08

Last Posted Date: 2025-05-16

Lead Sponsor: University of Birmingham

Target Recruit Count: 3000

Registration Number: NCT04700826

Locations: 🇬🇧
University Hospitals Birmingham, Birmingham, West Midlands, United Kingdom

Measuring the Quality of Surgical Care and Setting Benchmarks for Training Using Intuitive Data Recorder Technology

Active, not recruiting

Conditions: Cancer
Surgery

First Posted Date: 2020-11-30

Last Posted Date: 2023-09-26

Lead Sponsor: University of Birmingham

Target Recruit Count: 500

Registration Number: NCT04647188

Locations: 🇬🇧
University Hospitals Coventry & Warwickshire NHS Trust, Coventry, United Kingdom
🇬🇧
Golden Jubilee National Hospital, Glasgow, United Kingdom
🇬🇧
Royal Surrey NHS Foundation Trust, Guildford, United Kingdom

and more 12 locations

FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma

Phase 1

Recruiting

Conditions: Rhabdomyosarcoma

Interventions: Radiation: radiotherapy
Drug: Irinotecan
Drug: Vinorelbine
Drug: Actinomycin D
Drug: Doxorubicin
Drug: Cyclophosphamide
Drug: Ifosfamide
Drug: Temozolomide
Drug: Regorafenib
Drug: Vincristine

First Posted Date: 2020-11-12

Last Posted Date: 2024-05-23

Lead Sponsor: University of Birmingham

Target Recruit Count: 1672

Registration Number: NCT04625907

Locations: 🇦🇺
Queensland Children's Hospital, Brisbane, Australia
🇦🇺
Chris O'brien Lifehouse, Camperdown, Australia
🇦🇺
Monash Children's Hospital, Clayton, Australia

and more 125 locations

ColoRectal Cancer in India: catastrOphiC expenDIture and Referral Pathways infLuencE on Presentation and Treatment

Conditions: Treatment Compliance
Colorectal Cancer
Health Care Utilization

First Posted Date: 2020-08-18

Last Posted Date: 2020-08-18

Lead Sponsor: University of Birmingham

Target Recruit Count: 200

Registration Number: NCT04517032

GlobalSurg-CovidSurg Week

Conditions: Surgery
Covid19
Post-Op Complication

First Posted Date: 2020-08-12

Last Posted Date: 2020-08-12

Lead Sponsor: University of Birmingham

Target Recruit Count: 1000

Registration Number: NCT04509986

Preventing Bed-rest Induced Muscle Loss in the Elderly

Not Applicable

Completed

Conditions: Protein Metabolism
Prehabilitation
Muscle Loss
Disuse Atrophy
Sarcopenia

First Posted Date: 2020-06-09

Last Posted Date: 2020-06-09

Lead Sponsor: University of Birmingham

Target Recruit Count: 20

Registration Number: NCT04422665

Locations: 🇬🇧
University of Birmingham, School of Sport, Exercise and Rehabilitation Sciences, Edgbaston, West Midlands, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy